文献速递神经肿瘤

胶质母细胞瘤周边的干性标志物检测及胶质母细胞瘤生成胶质瘤干细胞的能力:临床相关性

Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
PubMed 文献 · World Neurosurg · 2017-05-27

研究对20例胶质母细胞瘤(GBM)肿瘤核心与周边癌细胞进行表型分析,发现核心与周边甲基鸟嘌呤-DNA甲基转移酶水平相似而周边Ki-67降低,仅SOX2>30%的细胞能产生神经球,GSC体外生成与Ki-67>5%共表达与不良结局负相关。

要点

  • 仅表达SOX2>30%的GBM细胞能够产生神经球。
  • GSC体外生成与Ki-67>5%共表达和结局呈负相关。
  • GBM肿瘤周边存在干性标志物和MGMT可能是治疗失败与复发的原因。

核心结论

  • 并非所有GBM培养物都能生成GSC,该能力与SOX2>30%水平相关。
  • 成球能力与生存呈负相关,检测Ki-67>5%可能有助于识别疾病进展风险患者。
  • GSC-/SOX-2-/Ki-67-细胞的存在可能被视为新的预后因素。
  • GBM肿瘤周边存在干性标志物和甲基鸟嘌呤-DNA甲基转移酶可能是治疗失败和复发的原因。
  • 开发靶向干细胞的疗法及制定更积极的治疗可能有助于消除GBM来源和复发灶。

研究设计与样本

  • 对20例GBM肿瘤的核心与周边癌细胞进行表型特征分析。
  • 将临床结局与生成GSC的能力进行关联,并依据Ki-67染色区分生存。

主要发现

  • GBM肿瘤核心与周边的甲基鸟嘌呤-DNA甲基转移酶水平相似,而周边Ki-67降低。
  • 所有GBM培养物中周边与核心的干性标志物水平相似。
  • 仅表达SOX2>30%的细胞能够产生神经球。
  • 免疫表型分析显示GSC培养物中干性标志物水平高于所有GBM原代培养物。
  • GSC体外生成与Ki-67>5%共表达与结局呈负相关。

关键数值与推荐

  • 仅表达SOX2>30%的细胞能够产生神经球。
  • GSC体外生成与Ki-67>5%共表达与结局呈负相关。

临床怎么用

  • 检测Ki-67>5%可能有助于识别疾病进展风险患者。
  • GSC-/SOX-2-/Ki-67-细胞的存在可能被视为新的预后因素。
  • 作者认为开发靶向干细胞的疗法及制定更积极的治疗可能有助于消除GBM来源和复发灶。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies suggested glioma stem cells (GSCs) are key contributors to therapeutic resistance of glioblastoma multiforme (GBM) and are responsible for GBM recurrence. METHODS: We characterized the phenotype of cancer cells in the core and periphery of 20 GBM tumors, correlating clinical outcome to the ability to form GSCs and distinguishing survival based on Ki-67 staining. RESULTS: Similar levels of methylguanine-deoxyribonucleic acid methyltransferase were found in the core and periphery of GBM tumors, whereas Ki-67 was reduced in the periphery. Similar levels of stemness markers in the periphery and in the core of all GBM cultures were found. Only cells expressing >30% SOX2 levels were able to produce neurospheres. Immunophenotypic analysis showed higher levels of stemness markers in GSC cultures than in all GBM primary cultures. GSC in vitro production and coexpression of Ki-67 >5% negatively correlated with outcome. CONCLUSIONS: Not all GBM cultures can generate GSCs, and this capacity is linked to >30% SOX2 levels. The ability to form spheres negatively correlated to survival, and the detection of >5% Ki-67 levels may be useful to identify patients at risk of disease progression. The presence of GSC-/SOX-2-/Ki-67- cells may be regarded as a new prognostic factor. The presence of stemness markers and methylguanine-deoxyribonucleic acid methyltransferase in the periphery of GBM tumors may be the reason for treatment failure and recurrence. Development of stem cell-targeted therapies and elaboration of more aggressive treatments represent an opportunity to eliminate the GBM source and the nidus of recurrence.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Raysi Dehcordi S, Ricci A, Di Vitantonio H, et al. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations. World Neurosurg. 2017. PMID: 28559081. doi:10.1016/j.wneu.2017.05.099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。